Coverage
Filings
| Filing | Date |
|---|---|
| Major shareholder announcement | 5 Sept 2024 |
| Trading by management and close relations of management | 2 Sept 2024 |
| Trading by management and close relations of management | 2 Sept 2024 |
| Trading by management and close relations of management | 30 Aug 2024 |
| Major shareholder announcement | 29 Aug 2024 |
| Novonesis increases outlook for full year 2024 | 27 Aug 2024 |
| Interim Report H1 2024 | 27 Aug 2024 |
| Major shareholder announcement |
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 16 Aug 2024 |
| Major shareholder announcement | 26 Jun 2024 |
| Trading by management and close relations of management | 21 Jun 2024 |
| Major shareholder announcement | 21 Jun 2024 |
| The era of biosolutions. Outlook upgraded for 2024 | 17 Jun 2024 |